Stock Events

Stock Events

Search...

CRISPR Therapeutics (CRSP) Q2 2025 Earnings

6MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.58

-1.2

-0.82

-0.44

Details

Expected EPS

-1.243557

Actual EPS

-1.58

Surprise EPS

-0.34

Surprise Percent

+27.05%

Description

CRISPR Therapeutics (CRSP) has reported earnings of -1.58 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.